Indiana’s life sciences initiative has been awarded a two-year, $2.9 million grant from Lilly Endowment Inc. BioCrossroads says the funding will support its ongoing charitable, educational and scientific efforts.
BioCrossroads Chief Executive Officer David Johnson says the grant comes at a "pivotal point in the advancement of the state’s life sciences industry." The funding will go to the Central Indiana Corporate Partnership Foundation.
The organization says, to date, it has raised more than $377 million in grant money. CICP and BioCrossroads say the funding has supported major projects including the establishment of the Indiana Health Information Exchange, the Indiana I-STEM Network and the Datalys Center for Sports Injury Research. It has also boosted the state’s orthopedic initiative OrthoWorx and agriculture innovation initiative AgriNovus Indiana.